Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FHL2 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | PLS3 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0004 |
mRNA | SLAMF6 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | MAPT | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | CPQ | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | VASN | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | PRPF4B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | GCNT2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | CCL4 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | DCAF1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |